Acura Pharmaceuticals (ACUR) Stock Chart & Stock Price History $0.0003 0.00 (-94.00%) As of 02:44 PM Eastern Add Compare Share Share Chart Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Acura Pharmaceuticals Stock Price Performance The Acura Pharmaceuticals (ACUR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 91.67%, with a year-to-date return of 50.00%. In the past month, the stock has increased 50.00%, reflecting recent market activity. As of the latest close, Acura Pharmaceuticals traded at $0.01 with a market cap of $332 thousand and volume of 1,843 shares. Five years ago, the stock traded at $0.25, representing a 99.88% decrease over that period. At the time, it had a market cap of $6.24 million and a volume of 1,257 shares. Receive ACUR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-40.00%1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date Performance+50.00%1 Year Performance-91.67%5 Year Performance-99.88% ACUR Stock Chart for Monday, August, 18, 2025 ACUR Chart by TradingView Acura Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$0.01$0.01$0.01$0.001,843 shs$332,000.0008/14/2025$0.00$0.01+900.00%$0.01$0.001,843 shs$332,000.0008/13/2025$0.00$0.00$0.00$0.005,000 shs$33,000.0008/12/2025$0.00$0.00$0.00$0.005,000 shs$33,000.0008/11/2025$0.00$0.00$0.00$0.005,000 shs$33,000.0008/07/2025$0.00$0.00$0.00$0.001,904 shs$33,000.0008/06/2025$0.00$0.00$0.00$0.001,904 shs$33,000.0008/01/2025$0.00$0.00$0.00$0.0028 shs$33,000.0007/30/2025$0.00$0.00$0.00$0.00757 shs$33,000.0007/29/2025$0.00$0.00$0.00$0.00757 shs$33,000.0007/25/2025$0.00$0.00$0.00$0.00800 shs$33,000.0007/24/2025$0.01$0.00-95.00%$0.00$0.00800 shs$33,000.0007/23/2025$0.01$0.01$0.01$0.011,000 shs$665,000.0007/22/2025$0.00$0.01+4,900.00%$0.01$0.011,000 shs$665,000.00 Related Companies LLY Stock Chart JNJ Stock Chart ABBV Stock Chart MRK Stock Chart PFE Stock Chart BMY Stock Chart ZTS Stock Chart RPRX Stock Chart CORT Stock Chart JAZZ Stock Chart Receive ACUR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ACUR) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acura Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acura Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access